KN 203
Alternative Names: GRT 203; KN203Latest Information Update: 20 Aug 2015
Price :
$50 *
At a glance
- Originator Grunenthal
- Developer KeyNeurotek Pharmaceuticals AG
- Class Small molecules; Urologics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 14 May 2007 Phase-I clinical trials in Urinary incontinence in Germany (PO)